$NVAX Again, don't worry about the ups and downs or the effects of negative articles at this point. Of course the share price is still easy to manipulate because the company is still in the process of launching and there are still question marks. Once they have widespread authorizations as a heterologous booster and they have their variant-specific vaccine ready to go, then they will actually be able to participate in the market. Hopefully, this will happen in time for the upcoming surge in demand. Then the share price will no longer be arbitrary and will actually be based on quality, demand, and earnings . . . imagine!